Not for male sterility or impotence. Discontinue if severe application site reaction develops; in patients suffering from severe cardiac, hepatic or renal insufficiency. Increased risk of sleep apnoea in patients w/ risk factors eg, obesity & chronic resp disease. Risk of testosterone transfer. Hypercalcaemia; HTN; epilepsy, migraine; ischemic heart disease; major risk of non-compliance w/ safety instructions eg, severe alcoholism & psychiatric disorders, drug abuse. Development of acne or hair modification. May produce +ve reaction in anti-doping tests. Perform careful & regular monitoring of prostate gland & breast by digital rectal exam & serum PSA estimation at least once yrly & twice yrly in elderly. Regular monitor serum Ca conc. Periodically check Hb, hematocrit, liver function, & determine lipid profile. Observe a long interval between application & sexual intercourse; wear Tshirt covering application site, during contact period or to shower before sexual intercourse. Not to be used by women. Males <18 yr. Pregnant women should avoid contact w/ application sites. Not to be used in pregnancy & lactation. Childn.
Sign Out
